Targeting RSV-neutralizing B cell receptors with anti-idiotypic antibodies.
Scharffenberger SC, Wan YH, Homad LJ, Kher G, Haynes AM, Poudel B, Sinha IR, Aldridge N, Pai A, Bibby M, Chhan CB, Davis AR, Moodie Z, Palacio MB, Escolano A, McElrath MJ, Boonyaratanakornkit J, Pancera M, McGuire AT.
Scharffenberger SC, et al. Among authors: davis ar.
Cell Rep. 2024 Oct 22;43(10):114811. doi: 10.1016/j.celrep.2024.114811. Epub 2024 Oct 8.
Cell Rep. 2024.
PMID: 39383036
Free PMC article.